Home
>
National Drug Code (NDC)
>
Rhizopus
Rhizopus - 49643-118-10 - (Rhizopus oryzae)
Drug Information of Rhizopus
| Product NDC: | 49643-118 |
| Proprietary Name: | Rhizopus |
| Non Proprietary Name: | Rhizopus oryzae |
| Active Ingredient(s): | 1 g/10mL & nbsp; Rhizopus oryzae |
| Administration Route(s): | CUTANEOUS; INTRADERMAL; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Rhizopus
| Product NDC: | 49643-118 |
| Labeler Name: | Allermed Laboratories, Inc. |
| Product Type: | NON-STANDARDIZED ALLERGENIC |
| FDA Application Number: | BLA102212 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19740312 |
Package Information of Rhizopus
| Package NDC: | 49643-118-10 |
| Package Description: | 10 mL in 1 VIAL, MULTI-DOSE (49643-118-10) |
NDC Information of Rhizopus
| NDC Code | 49643-118-10 |
| Proprietary Name | Rhizopus |
| Package Description | 10 mL in 1 VIAL, MULTI-DOSE (49643-118-10) |
| Product NDC | 49643-118 |
| Product Type Name | NON-STANDARDIZED ALLERGENIC |
| Non Proprietary Name | Rhizopus oryzae |
| Dosage Form Name | INJECTION |
| Route Name | CUTANEOUS; INTRADERMAL; SUBCUTANEOUS |
| Start Marketing Date | 19740312 |
| Marketing Category Name | BLA |
| Labeler Name | Allermed Laboratories, Inc. |
| Substance Name | RHIZOPUS ARRHIZUS VAR. ARRHIZUS |
| Strength Number | 1 |
| Strength Unit | g/10mL |
| Pharmaceutical Classes | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
